Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NBTY seals Leiner deal

This article was originally published in The Tan Sheet

Executive Summary

Nutritional supplement manufacturer and marketer NBTY announced July 14 it completed its purchase of substantially all Leiner Health Products' assets for $371 million (1"The Tan Sheet" June 16, 2008, p. 3)...

You may also be interested in...



NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins

NBTY plans to raise prices for its Nature's Bounty brand dietary supplements in January 2009 following a 63.8 percent decrease in net income in its latest earnings period

NBTY Leiner Buy Intensifies Supplement Ingredient Competition

The dietary supplement ingredient supply market is set to become more competitive with NBTY's planned acquisition of Leiner Health Products

Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.

Topics

UsernamePublicRestriction

Register

PS101893

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel